Genetic Technologies (GENE) Stock Price, News & Analysis
Company Description
Genetic Technologies (NASDAQ: GENE) is classified in the testing laboratories industry within the Professional, Scientific, and Technical Services sector and carries a market capitalization of $3.7M, ranking #7,027 among all listed U.S. companies by market cap.
GENE has declined 78.0% over the past year. Shares last traded at $0.7650.
This page collects what Stock Titan holds for GENE, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Genetic Technologies (GENE) stock last closed at $0.7650. Over the past 12 months, the stock has lost 78.0%. At a market capitalization of $3.7M, GENE is classified as a micro-cap stock.
GENE Rankings
Latest News
Genetic Technologies has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include management. View all GENE news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
GENE Company Profile & Sector Positioning
Genetic Technologies (GENE) operates in the Testing Laboratories industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NASDAQ.